Elise M. Bekers
Papers
9
Total Citations
172
H-Index
8
About
Dr. Elise M. Bekers is a pioneering surgical oncologist whose research focuses on advancing precision surgery for prostate cancer through molecular imaging and targeted therapeutics. Her landmark first-in-patient phase 2a trial (2023, 54 citations) demonstrated the clinical feasibility of OTL78 for intraoperative fluorescence imaging of PSMA-positive prostate cancer, establishing a new paradigm for real-time tumor visualization during surgery. Dr. Bekers has made seminal contributions to sentinel node mapping, showing through a randomized phase II trial (2021, 31 citations) that intratumoral versus intraprostatic tracer injection significantly impacts nodal drainage detection. Her work on PSMA PET/CT staging (2022, 22 citations) has clarified the prognostic value of molecular imaging in node-positive disease, while her investigations into non-PSMA-expressing primary tumors (2022, 9 citations) have illuminated important biological heterogeneity. Dr. Bekers has also advanced focal laser ablation monitoring using MRI and contrast-enhanced ultrasound (2023, 14 citations), and pioneered multispectral fluorescence imaging to distinguish pelvic lymphatic drainage patterns during robotic lymph node dissection (2024). Her cumulative work, spanning over 170 citations, is redefining how surgeons visualize, stage, and treat prostate cancer at the microscopic level.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9